Annual report pursuant to Section 13 and 15(d)

Consolidated Balance Sheets

v3.23.1
Consolidated Balance Sheets - USD ($)
Dec. 31, 2022
Dec. 31, 2021
Current Assets:    
Cash and cash equivalents $ 14,739,484 $ 24,907,963
Accounts receivable, net 135,658 2,291,533
Other receivables   526,070
Prepaid expenses and other current assets 346,935 495,178
Total Current Assets 15,222,077 28,220,744
Intangible assets, net   2,946,610
Goodwill   463,000
Property and equipment, net   44,756
Deferred financing costs 10,000 10,000
Total Assets 15,232,077 31,685,110
Current Liabilities:    
Accounts payable - suppliers 673,781 1,844,544
Accounts payable - trade 816,190 659,362
Accrued expenses and other current liabilities 830,365 2,493,287
Deferred revenue 28,403 395,914
Current portion of notes payable   151,336
Total Current Liabilities 2,348,739 5,544,443
Contingent consideration   613,000
Notes payable, non-current portion 78,900 77,407
Total Liabilities 2,427,639 6,234,850
Commitments and contingencies
Stockholders' Equity:    
Preferred stock, $0.00001 par value; 5,000,000 shares authorized; No shares issued and outstanding as of September 30, 2022 and December 31, 2021
Common stock, $0.00001 par value; 95,000,000 shares authorized; 14,402,500 and 14,253,948 shares issued and outstanding as of September 30, 2022 and December 31, 2021, respectively 145 143
Additional paid-in capital 53,004,967 52,030,907
Accumulated deficit (40,200,674) (26,580,790)
Total Stockholders' Equity 12,804,438 25,450,260
Total Liabilities and Stockholders' Equity $ 15,232,077 $ 31,685,110